Dew, Yes, if I had gone short instead of long in every transaction I've had over the last 5 years, I'd own my own island in the Caribbean by now :o) The best decision I've made (financially and emotionally) has been to stay out of bio stocks altogether, and just follow them as a hobby.
BTW, I always thought Vertex looked like the best long term bet in the Hepatitis area, though they're still early stage and the stock is now very expensive (lots of competition in that space too). Idenix should get to market a lot sooner, and has a strong partnership, though their drug doesn't appear to have near the potential of Vertex's VX-950. I thought both stocks were worth owning though. Good luck!
It'll now be interesting to see whether COR and/or GTCB can emerge from the ashes.
Market Data 
Markets 
AI
